A randomize double-blinded, Placebo controlled, Phase II Trial of ANTI-PD1, TSR-042, as maintenance Therapy for patients with high-risk locallly advanced cervical cancer after chemo radiation
Trial Number
NCT03833479 (ClinicalTrials.gov Identifier)Contact Person
Status
Closed to Recruitment
Disease Site
Cervical